Who Owns IMRX?

Immuneering Corporation — Institutional Ownership & 13F Holdings

$5.28

-0.48 (-8.33%)

Market Cap

$209.1M

Shares Outstanding

36,302,338

Institutional Holders

35

Total Inst. Value

$5.7M

% of Float Held

17.8%

QoQ Holder Change

-10

Institutional data as of Q1 2025

New Positions

5

Closed Positions

13

Increased

9

Decreased

9

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$1.6M1,056,922
2PRICE T ROWE ASSOCIATES INC /MD/$1.0M659,009
3MORGAN STANLEY$709K467,226
4BlackRock, Inc.$481K316,530
5SOUTHPORT MANAGEMENT, L.L.C.$372K245,000
6GEODE CAPITAL MANAGEMENT, LLC$342K225,817
7HighTower Advisors, LLC$128K83,960
8MANUFACTURERS LIFE INSURANCE COMPANY, THE$126K82,667
9STATE STREET CORP$119K78,535
10TD ASSET MANAGEMENT INC$108K71,066

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold IMRX?

As of Q1 2025, 35 institutional investors report holding IMRX (Immuneering Corporation) in their 13F filings.

What percentage of Immuneering Corporation is owned by institutions?

Institutional investors hold approximately 17.8% of Immuneering Corporation's float as reported in SEC 13F filings.

Which hedge fund owns the most IMRX?

The largest institutional holder of IMRX is VANGUARD GROUP INC with $1.6M in shares.

Are institutions buying or selling IMRX?

This quarter, 5 institutions opened new positions in IMRX and 13 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.